SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 24th, 2020 • Invitae Corp • Services-medical laboratories • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 21, 2020 by and among Invitae Corporation, a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
AGREEMENT AND PLAN OF MERGER AND PLAN OF REORGANIZATION among INVITAE CORPORATION, APOLLO MERGER SUB A INC., APOLLO MERGER SUB B LLC, ARCHERDX, INC. and KYLE LEFKOFF, solely in his capacity as HOLDERS’ REPRESENTATIVE June 21, 2020Merger Agreement • June 24th, 2020 • Invitae Corp • Services-medical laboratories • Delaware
THIS AGREEMENT AND PLAN OF MERGER AND PLAN OF REORGANIZATION (this “Agreement”) is entered into and dated as of June 21, 2020 (the “Agreement Date”) by and among: (i) Invitae Corporation, a Delaware corporation (“Parent”); (ii) Apollo Merger Sub A Inc., a Delaware corporation and a wholly owned, direct subsidiary of Parent (“Merger Sub A”); (iii) Apollo Merger Sub B LLC, a Delaware limited liability company and a wholly owned, direct subsidiary of Parent (“Merger Sub B” and with Merger Sub A, each a “Merger Sub” and together, the “Merger Subs”); (iv) ArcherDX, Inc., a Delaware corporation (the “Company”); and (v) Kyle Lefkoff, solely in his capacity as the representative, agent and attorney-in-fact of the Holders (the “Holders’ Representative”), but solely with respect to the provisions expressly applicable to the Holders’ Representative as set forth herein. Each of Parent, Merger Sub A, Merger Sub B, the Company and the Holders’ Representative may be individually referred to herein as
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 24th, 2020 • Invitae Corp • Services-medical laboratories • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of , 2020 by and among Invitae Corporation, a Delaware corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of June 21, 2020 (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
